Recs

0

Market's Knickers in a Twist

Mr. Market, you must chill. I do declare, if you keep getting all worked up over nothing, you're going to give yourself a heart attack.

On Thursday, through simultaneous filings with the Securities and Exchange Commission, ceramics specialist Ceradyne (Nasdaq: CRDN  ) announced its intent to raise cash to pay off a $111 million credit facility (a fancy name for debt), fund acquisitions, and generally fill its corporate war chest to the brim. To raise the cash, Ceradyne will float between 1.8 million and 2.1 million new shares of common stock -- at a price to be determined by Ceradyne and its advisors, including Citigroup (NYSE: C  ) and Wachovia (NYSE: WB  ) -- and between $100 million and $110 million in senior subordinated convertible notes (another fancy name for debt).

Net result: Debt will hold steady at about $110 million or so, and the company will reap as much as $91 million (before the investment banks take their cut) with which to buy up competitors, expand production, and so on. In addition, the company's share count will jump to anywhere from 26.5 million to 26.7 million, depending on whether the investment banks exercise none, some, or all of their 270,000-share overallotment options.

In other words, nothing much is happening. When a company replaces $110 million or so in one flavor of debt with $110 million in debt of another flavor, it's a non-event. And when a company whose share price has roughly doubled over the past six months decides to convert some of that equity into cash that it can use as it wishes, this is at worst a non-event and at best an excellent opportunity to reward existing shareholders by relieving new shareholders of their hard-earned cash.

Yes, I know that Friedman Billings Ramsey (NYSE: FBR  ) says that this share issuance "introduces too much dilution." And, yes, issuing all these new shares will increase Ceradyne's share count by about 8%. But so what? Pre-dilution, an owner of 100 shares of Ceradyne owned 0.0000040% of a company with $99 million in net debt. Post-dilution, that same owner will own .0000037% of a company with $8 million in net debt. The shareholder's percentage ownership decreases, but the value of the company owned increases, basically balancing out the equation.

It's really nothing to get worked up about, Ceradyne shareholders. And certainly not worth slicing $84 million off the company's market cap. So I repeat: Mr. Market, you must chill.

Why has Ceradyne doubled in six months? Read all about it in:

Fools, now is the time to open your hearts and wallets to worthy causes! Please support our five Foolish charities at www.foolanthropy.com.

Fool contributor Rich Smith does not own shares in any company named above.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 498459, ~/Articles/ArticleHandler.aspx, 5/23/2012 12:17:19 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,331.61 -171.20 -1.37%
S&P 500 1,298.66 -17.97 -1.36%
NASD 2,799.76 -39.32 -1.38%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/23/2012 12:00 PM
FBR $6.41 Down -0.12 -1.84%
Votorantim Celulos… CAPS Rating: ***
WB $5.54 Down +0.00 +0.00%
Wachovia Corp CAPS Rating: **
C $26.22 Down -0.70 -2.60%
Citigroup Inc CAPS Rating: ***
CRDN $24.04 Down -0.56 -2.28%
Ceradyne CAPS Rating: ****

Advertisement